Abstract:Background and purpose:Choriocarcinoma is a highly malignant tumor,which metastasis could occur at early stage,the molecular mechanism is still under investigation.DLX4 is a member of homeodomain transcriptional factors,and its abnormal expression has a close correlation with mammary cancer,colon caner and so on.Based on our previous study that DLX4 was highly expressed in choriocarcinoma JEG-3 cell lines,we used RNAi to knock down the expression of DLX4,and aimed to explore the effect of DLX4 on the adhesion,movement and invasion ability of choriocarcinoma cells.Methods:DLX4 siRNA and control siRNA plasmid were constructed and transfected into choriocarcinoma cell line JEG-3 cells with LipofectamineTM2000.JEG-3 cells that expressed high level of DLX4 siRNA and control siRNA plasmid were selected and maintained with G418.The effect of RNAi was detected by western blot,and then the adhesion,movement and invasion ability of JEG-3 cells were investigated by cell-ECM adhesion assay,Transwell chamber and Transwell-Matrigel model,respectively.Results:DLX4 RNAi inhibited DLX4 protein expression specifically and effectively.The adhesion rate of the cells in JEG-3 siDLX4 group was(30.6±4.2)%,which was significantly less than(57.2±4.0)% in JEG-3 without transfenction and(51.6±3.9)% in JEG-3 scDLX4 groups(P0.01 and P0.05,respectively).The movement and invasion ability were evidently inhibited in JEG-3 siDLX4 group compared with those in JEG-3 non-transfenction and JEG-3 scDLX4 groups [(31±3),(21±4)/HP vs.(68±5),(64±4)/HP and(70±4),(67±5)/HP,respectively,P0.01],while the adhesion,movement and invasion ability of the cells between JEG-3 non-transfenction and JEG-3 scDLX4 groups were not different(all of P0.05).Conclusions:The knock-down of DLX4 by RNAi could prevent the adhesion and invasion ability of choriocarcinoma cells,which provides a new thought for further research in invasion and metastasis of choriocarcinoma.

[Inhibitory Effect of LRRC4 on the Mobility and Invasion of Glioblastomas Through the SDF-1alpha/CXCR4 Axis].

Lrrc4 Inhibits Mobility And Invasion Through The Sdf-1a/Cxcr4 Axis In U251 Cells

LRRC4 Inhibits Human Glioblastoma Cells Proliferation, Invasion, and Prommp‐2 Activation by Reducing SDF‐1α/CXCR4‐mediated ERK1/2 and Akt Signaling Pathways

Suppression Of Growth And Invasion Phenotypes In Glioblastoma U251 Cells By The Lrr Domain Of Lrrc4

Suppression of Growth and Invasion Phenotypes in Glioblastoma U251 Cells by LRR Domain of LRRC4

LRRC4 Controls in Vitro Invasion of Glioblastoma Cells Through Inhibiting RPTP-zeta Expression.

Expression of LRRC4 Has the Potential to Decrease the Growth Rate and Tumorigenesis of Glioblastoma Cell Line U251.

LRRC4 inhibits glioblastoma cell proliferation, migration, and angiogenesis by downregulating pleiotropic cytokine expression and responses.

Blockage of U251 Cells in G0/G1 Through MAPK Signaling Pathway by LRRC4

LRRC4 inhibits glioma cell growth and invasion through a miR-185-dependent pathway.

The Inhibitory Effect of DLX4 RNAi on Adhesion and Invasion Ability of Choriocarcinoma Cells

Expression and Functional Characterization of LRRC4, a Novel Brain‐specific Member of the LRR Superfamily

Progress in LRRC4, a Novel Brain-specific Gene/Glioma Suppressive Gene

LRRC4 inhibits the proliferation of human glioma cells by modulating the expression of STMN1 and microtubule polymerization.

Function of a Novel Brain-Specific Gene LRRC4

Study of a novel brain relatively specific gene LRRC4 involved in glioma tumorigenesis suppression using the Tet-on system.

Down-regulation of CXCR4 expression inhibits invasion and VEGF production of glioma stem cells

Membrane-bound Transcription Factor LRRC4 Inhibits Glioblastoma Cell Motility.

Establishment Of Brain Relatively Specific Gene Lrrc4 With Doxycycline Induced Tet Regulating System In U251 Glioblatoma Cell Line

The Role of SDF-1/CXCR4 Axis in Proliferation,Migration and Invasion of Malignant Glioma Cell Lines

LRRC4, a Putative Tumor Suppressor Gene, Requires a Functional Leucine-Rich Repeat Cassette Domain to Inhibit Proliferation of Glioma Cells in Vitro by Modulating the Extracellular Signal-Regulated Kinase/protein Kinase B/nuclear Factor-Kappab Pathway.